139 related articles for article (PubMed ID: 15202102)
1. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
2. Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.
Peng NJ; Hu C; King TM; Chiu YL; Wang JH; Liu RS
Cancer Biother Radiopharm; 2013; 28(6):479-87. PubMed ID: 23713869
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET in colorectal cancer.
de Geus-Oei LF; Ruers TJ; Punt CJ; Leer JW; Corstens FH; Oyen WJ
Cancer Imaging; 2006 Oct; 6(Spec No A):S71-81. PubMed ID: 17114081
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography scanning is coming to a hospital near you soon!
Bashir H; Shabo G; Nunan TO
Clin Med (Lond); 2008 Apr; 8(2):134-9. PubMed ID: 18478853
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18 F-FDG PET/CT.
Habouzit V; Maoui K; Prevot N; Forest F; Grange R
Clin Nucl Med; 2024 May; 49(5):475-477. PubMed ID: 38465959
[TBL] [Abstract][Full Text] [Related]
6. Role of Integrated PET/CT Fusion in Lung Carcinoma.
Joshi SC; Pant I; Khan FA; Shukla AN; Gokula K
Int J Health Sci (Qassim); 2008 Jan; 2(1):97-101. PubMed ID: 21475478
[TBL] [Abstract][Full Text] [Related]
7. The new-generation positron emission tomography/computed tomography scanners: implications for cardiac imaging.
Bacharach SL
J Nucl Cardiol; 2004; 11(4):388-92. PubMed ID: 15295407
[No Abstract] [Full Text] [Related]
8. 3DFRINet: A Framework for the Detection and Diagnosis of Fracture Related Infection in Low Extremities Based on
Li C; Nie L; Sun Z; Ding X; Luo Q; Shen C
Comput Med Imaging Graph; 2024 May; 115():102394. PubMed ID: 38714019
[TBL] [Abstract][Full Text] [Related]
9. PET/CT: Role in staging, in follow-up and in the evaluation of disease recurrence in gynecologic cancer.
Skoura E
Hell J Nucl Med; 2023; 26 Suppl():85. PubMed ID: 37658571
[No Abstract] [Full Text] [Related]
10. Interventional Molecular Imaging.
Solomon SB; Cornelis F
J Nucl Med; 2016 Apr; 57(4):493-6. PubMed ID: 26912443
[TBL] [Abstract][Full Text] [Related]
11. The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma.
O'Connor OJ; McDermott S; Slattery J; Sahani D; Blake MA
Int J Surg Oncol; 2011; 2011():846512. PubMed ID: 22312527
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT images of COVID-19: a comprehensive review.
Minamimoto R; Hotta M; Ishikane M; Inagaki T
Glob Health Med; 2020 Aug; 2(4):221-226. PubMed ID: 33330811
[TBL] [Abstract][Full Text] [Related]
13. Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Chen SH; Miles K; Taylor SA; Ganeshan B; Rodriquez M; Fraioli F; Wan S; Afaq A; Shortman R; Walls D; Hoy L; Endozo R; Bhargava A; Hanson M; Huang J; Raouf S; Francis D; Siddiqi S; Arulampalam T; Sizer B; Machesney M; Reay-Jones N; Dindyal S; Ng T; Groves AM
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):786-787. PubMed ID: 34894284
[No Abstract] [Full Text] [Related]
14. Inpatient FDG PET/CT: Counterpoint-A Costly Yet Subpar Evaluation That Prolongs Hospital Length of Stay.
Dietsche E; Scaringi J
AJR Am J Roentgenol; 2024 Jan; ():. PubMed ID: 38197757
[No Abstract] [Full Text] [Related]
15. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
[TBL] [Abstract][Full Text] [Related]
16. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
17. FDG PET and PET/CT for colorectal cancer.
Delbeke D; Martin WH
Methods Mol Biol; 2011; 727():77-103. PubMed ID: 21331930
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation.
Dhoundiyal S; Srivastava S; Kumar S; Singh G; Ashique S; Pal R; Mishra N; Taghizadeh-Hesary F
Eur J Med Res; 2024 Jan; 29(1):26. PubMed ID: 38183131
[TBL] [Abstract][Full Text] [Related]
19. Tailoring the clinical management of colorectal cancer by
Shi Y; Wang M; Zhang J; Xiang Z; Li C; Zhang J; Ma X
Front Oncol; 2022; 12():1062704. PubMed ID: 36620584
[TBL] [Abstract][Full Text] [Related]
20. Correlations among KRAS Mutation, Microsatellite Instability, and 18F-FDG Uptake in Colon Cancer.
Lee SS; Choi SJ; Park JS
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3501-3506. PubMed ID: 36308376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
